Updates from some of our outstanding ASPET members.
ASPET’s public policy efforts play a pivotal role in shaping the science advocacy conversation. From advocating on Capitol Hill—including the ASPET Council and early-career members—to advocacy letter campaigns, the Society remains committed to keeping pharmacologists involved in the public conversation.
A showcase of three early-career scientists—what drives them and why pharmacology is important to them.
Honoring ASPET members who have passed.
ASPET Journals Name Three New Associate Editors
Mention Goodman and Gilman to any pharmacologist, and they will automatically think of their graduate school textbook.
Listen to ASPET President Namandjé N. Bumpus, PhD as she discusses the new look of The Pharmacologist, important happenings within ASPET and some upcoming highlights on the ASPET 2024 Annual Meeting.
As your Executive Officer, it is my privilege to “be handed the torch” from ASPET’s storied and accomplished past and carry it into the next phase for our Society. It is truly inspiring to think about the many revered programs, products and services that ASPET has been carrying on for decades to benefit the pharmacology community. Among them, we’re excited for this January 2024 issue to serve as the latest evolution of The Pharmacologist.
A Conversation with ASPET’s President-Elect Carol Beck, PharmD, PhD
Updates from some of our outstanding ASPET members.
